Year |
Citation |
Score |
2007 |
Matas D, Juknat A, Pietr M, Klin Y, Vogel Z. Anandamide protects from low serum-induced apoptosis via its degradation to ethanolamine. The Journal of Biological Chemistry. 282: 7885-92. PMID 17227767 DOI: 10.1074/Jbc.M608646200 |
0.346 |
|
2004 |
Matas D, Milyavsky M, Shats I, Nissim L, Goldfinger N, Rotter V. p53 is a regulator of macrophage differentiation. Cell Death and Differentiation. 11: 458-67. PMID 14713961 DOI: 10.1038/Sj.Cdd.4401379 |
0.745 |
|
2001 |
Sigal A, Matas D, Almog N, Goldfinger N, Rotter V. The C-terminus of mutant p53 is necessary for its ability to interfere with growth arrest or apoptosis. Oncogene. 20: 4891-8. PMID 11521201 DOI: 10.1038/Sj.Onc.1204724 |
0.759 |
|
2001 |
Matas D, Sigal A, Stambolsky P, Milyavsky M, Weisz L, Schwartz D, Goldfinger N, Rotter V. Integrity of the N-terminal transcription domain of p53 is required for mutant p53 interference with drug-induced apoptosis. The Embo Journal. 20: 4163-72. PMID 11483519 DOI: 10.1093/Emboj/20.15.4163 |
0.633 |
|
2001 |
Offer H, Milyavsky M, Erez N, Matas D, Zurer I, Harris CC, Rotter V. Structural and functional involvement of p53 in BER in vitro and in vivo. Oncogene. 20: 581-9. PMID 11313990 DOI: 10.1038/Sj.Onc.1204120 |
0.579 |
|
1999 |
Offer H, Wolkowicz R, Matas D, Blumenstein S, Livneh Z, Rotter V. Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery. Febs Letters. 450: 197-204. PMID 10359074 DOI: 10.1016/S0014-5793(99)00505-0 |
0.75 |
|
1998 |
Li R, Sutphin PD, Schwartz D, Matas D, Almog N, Wolkowicz R, Goldfinger N, Pei H, Prokocimer M, Rotter V. Mutant p53 protein expression interferes with p53-independent apoptotic pathways. Oncogene. 16: 3269-77. PMID 9681825 DOI: 10.1038/Sj.Onc.1201867 |
0.777 |
|
Show low-probability matches. |